EUCTR2006-006887-44-GBActive, not recruitingPhase 1
on-invasive bed-side measurement of systemic endothelial function in patients undergoing abdominal aortic aneurysm repair; modulation by ascorbic acid - AAAAA
Royal Group Hospitals Trust0 sites31 target enrollmentStarted: May 15, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 31
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Adult patients admitted for elective open repair of AAA in the Royal Victoria Hospital, Belfast will be eligible for inclusion in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Exclusion criteria will be prior antioxidant therapy, known allergy to ascorbic acid or agents specified in the standardised anaesthetic protocol and lack of consent.
Investigators
Similar Trials
Completed
Phase 2
Ascorbic Acid in open Abdominal Aortic Aneurysm repairAbdominal aortic aneurysmAortic aneurysmISRCTN27369400Belfast Health and Social Care Trust (UK)31
Unknown
Not Applicable
on-invasive Assessment of a blood vessel in Children with Kawasaki DiseaseCTRI/2009/091/000894I45
Recruiting
Not Applicable
A New Noninvasive Method for Assessment of Endothelial function: Short Time Flow-Mediated Vasodilatiocardiovascular diseaseJPRN-UMIN000025458Division of Regeneration and Medicine, Hiroshima University Hospital50
Completed
Not Applicable
A New Noninvasive Method for Assessment of Endothelial Function: Enclosed Zone Flow-Mediated Vasodilation (ezFMD)healthy, cardiovascular diseaseJPRN-UMIN000004902Hiroshima University500
Completed
Not Applicable
A New Noninvasive Method for Assessment of Endothelial Function: Enclosed Zone Flow-Mediated Vasodilation (New ezFMD)healthy, cardiovascular diseaseJPRN-UMIN000013137Division of Regeneration and Medicine, Hiroshima University Hospital500